Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Eurelings

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Neurology|February 13, 2001
Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatideM Eurelings, K G Moons, N C Notermans, et al.
Leukemia|April 16, 2004
G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myelomaN W C J van de Donk, O de Weerdt, G Veth, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 4, 2014
Effectiveness of psychotherapy for severe somatoform disorder: meta-analysisJurrijn A Koelen, Jan H Houtveen, Allan Abbass, et al.
Plos One|October 18, 2019
Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosisLaura E M Eurelings, Jelle R Miedema, Virgil A S H Dalm, et al.
Neurology|September 2, 2009
Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathyM L Kuijf, M Eurelings, A P Tio-Gillen, et al.
Neurology|July 4, 2007
Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathyJ M F Niermeijer, M Eurelings, M W van der Linden, et al.
American Journal of Ophthalmology|March 22, 2022
Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of TherapyLaura E M Eurelings, Tom O A R Missotten, Mirjam E J van Velthoven, et al.
Journal of Hypertension|May 17, 2017
Lower dementia risk with different classes of antihypertensive medication in older patientsTessa van Middelaar, Lonneke A van Vught, Eric P Moll van Charante, et al.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Neurology|February 13, 2001
Neuropathy and IgM M-proteins: prognostic value of antibodies to MAG, SGPG, and sulfatideM Eurelings, K G Moons, N C Notermans, et al.
Leukemia|April 16, 2004
G3139, a Bcl-2 antisense oligodeoxynucleotide, induces clinical responses in VAD refractory myelomaN W C J van de Donk, O de Weerdt, G Veth, et al.
The British Journal of Psychiatry : the Journal of Mental Science|January 4, 2014
Effectiveness of psychotherapy for severe somatoform disorder: meta-analysisJurrijn A Koelen, Jan H Houtveen, Allan Abbass, et al.
Plos One|October 18, 2019
Sensitivity and specificity of serum soluble interleukin-2 receptor for diagnosing sarcoidosis in a population of patients suspected of sarcoidosisLaura E M Eurelings, Jelle R Miedema, Virgil A S H Dalm, et al.
Neurology|September 2, 2009
Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathyM L Kuijf, M Eurelings, A P Tio-Gillen, et al.
Neurology|July 4, 2007
Intermittent cyclophosphamide with prednisone versus placebo for polyneuropathy with IgM monoclonal gammopathyJ M F Niermeijer, M Eurelings, M W van der Linden, et al.
American Journal of Ophthalmology|March 22, 2022
Long-Term Follow-up of Patients With Uveitis Treated With Adalimumab: Response Rates and Reasons for Discontinuation of TherapyLaura E M Eurelings, Tom O A R Missotten, Mirjam E J van Velthoven, et al.
Journal of Hypertension|May 17, 2017
Lower dementia risk with different classes of antihypertensive medication in older patientsTessa van Middelaar, Lonneke A van Vught, Eric P Moll van Charante, et al.
Journal of the Neurological Sciences|June 26, 2024
Influence of personalized extended interval dosing on the natalizumab wearing-off effect - a sub-study of the NEXT-MS trialA A Toorop, M H J Wessels, L M Y Gelissen, et al.
European Journal of Cancer (Oxford, England : 1990)|May 15, 2013
Rasch-built Overall Disability Scale for patients with chemotherapy-induced peripheral neuropathy (CIPN-R-ODS)D Binda, E K Vanhoutte, G Cavaletti, et al.
Pageof 6